Ep.50 - A Revolutionary NAD+ Pen

About this video

Seeds interviews a UK pharmaceutical executive whose company developed a prescription NAD+ pen, revisiting the NAD+ episode from earlier in the series. The guest argues that prescriber hesitancy, more than demand, has limited NAD+ use, because manufacturing quality in the wellness market is inconsistent; his firm approached the product like a conventional drug program, with formulation, sterile manufacturing, and quality validation, dispensed through a compounding pharmacy route. Seeds explains his own history with NAD+ as a short-term support while working to improve the cell’s own recycling pathway, and argues that measuring NAD+ in blood says nothing about levels inside cells. He also cautions that precursor products can affect methylation pools in ways users overlook, and both men note that NAD+ levels fall substantially with age.

Key takeaways

• Product quality and sterile manufacturing standards are, in the guest’s account, the bottleneck for injectable wellness therapies
• Seeds treats direct NAD+ support as temporary while the cell’s own recycling pathway is improved
• Blood NAD+ measurements do not reflect intracellular levels, Seeds argues
• Precursor supplements are not automatically benign; Seeds flags effects on methylation as underappreciated
• Prescription-only, pharmacy-dispensed models are presented as the safety-conscious route for injectables

Episode details: published June 30, 2026 · 86 views · 46:27 long. Summary written by Self Growth Videos from the episode itself. The peptide and cellular-medicine concepts described are Dr. William Seeds’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: the SSRP Institute sells clinician certification in peptide therapy.

← Previous: Ep.64 - The End of Symptoms Based Medicine is Here and It Changes Everything · Next: Ep.26 - The Latest Clinical Study on GLP 1 Receptor Agonists →

All Dr. William Seeds videos · Dr. William Seeds profile · SSRP Institute (official site)